Dawa

Dawa Limited, established in 1972, is a prominent pharmaceutical manufacturer headquartered in Nairobi, Kenya, operating within the Healthcare and Pharmaceuticals sectors. For decades, the company has been a key provider of essential products across East Africa through its specialized Animal Health and Human Health divisions, focusing on enhancing animal productivity and improving patient quality of life. Its strategic acquisition by Medisel (K) Ltd in 2004 significantly bolstered Dawa's position in the East African pharmaceutical landscape, enabling it to leverage its parent company's extensive network to broaden its market reach and operational footprint.

With a workforce of 500-1,000 employees, Dawa has successfully expanded its commercial operations into over 10 countries spanning Eastern, Central, and Western Africa. This expansive network ensures its pharmaceutical and healthcare products are accessible across virtually every African nation. The company's commitment to growth and market penetration is supported by its dedicated team, and insights into their leadership and structure can be explored by visiting Meet Dawa's team. Dawa's operational scale is further indicated by its revenue of $69.2M, reflecting its substantial market presence and economic contribution.

The company maintains a presence across 2 locations, underscoring its focused yet significant operational footprint. Dawa Limited's product portfolio includes pharmaceuticals, chemicals, animal health solutions, and human medicines, all developed with a strong emphasis on quality and efficacy. Its long history, dating back to 1972, signifies a deep understanding of the African healthcare market and a sustained commitment to serving its diverse populations with critical medical and veterinary supplies.